CIK: 0001802528
Total reported value
$1.4B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | DNTH | Dianthus Therapeutics INC | Stock-Other | 11.71% | +8.68% | +22.16% | |
| 2 | COGT | Cogent Biosciences INC | Stock-Other | 11.63% | -9.04% | +44.62% | |
| 3 | AXSM | Axsome Therapeutics INC | Stock-Healthcare | 8.91% | — | — | |
| 4 | APGE | Apogee Therapeutics INC | Stock-Other | 7.32% | -9.95% | — | |
| 5 | ELVN | Enliven Therapeutics INC | Stock-Other | 6.84% | +0.90% | — | |
| 6 | VRDN | Viridian Therapeutics INC | Stock-Other | 6.72% | -3.74% | — | |
| 7 | ORKA | Oruka Therapeutics INC | Stock-Other | 6.41% | +4.58% | +9.89% | |
| 8 | KNSA | Kiniksa Pharmaceuticals International, plc | Stock-Other | 6.19% | -4.14% | EXIT | |
| 9 | SRRK | Scholar Rock Holding CORP | Stock-Other | 6.11% | — | — | |
| 10 | SYRE | Spyre Therapeutics INC | Stock-Other | 6.06% | +4.62% | — | |
| 11 | NUVL | Nuvalent Inc-a | Stock-Other | 5.66% | -5.57% | EXIT | |
| 12 | ABVX | Abivax Sa-adr | Stock-Other | 5.45% | — | — | |
| 13 | ZBIO | Zenas Biopharma INC | Stock-Other | 3.78% | -2.78% | — | |
| 14 | JBIO | Jade Biosciences INC | Stock-Other | 2.50% | -0.73% | — | |
| 15 | CATBUSD | Astria Therapeutics INC | Stock-Other | 2.33% | — | — | |
| 16 | ✓ | Crescent Biopharma INC. | Stock-Other | 1.48% | +1.17% | — | |
| 17 | IKT | Inhibikase Therapeutics INC | Stock-Other | 0.89% | -0.30% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | COGT | Cogent Biosciences INC | +5.9% | +44.62% | Add |
| 2 | DNTH | Dianthus Therapeutics INC | +4.1% | +22.16% | Add |
| 3 | KNSA | Kiniksa Pharmaceuticals International, plc | +2.4% | — | Add |
| 4 | ZBIO | Zenas Biopharma INC | +1.5% | — | Unchanged |
| 5 | ORKA | Oruka Therapeutics INC | +1% | +9.89% | Add |
| 6 | VRDN | Viridian Therapeutics INC | -0.5% | — | Add |
| 7 | CATBUSD | Astria Therapeutics INC | -0.6% | — | Unchanged |
| 8 | SRRK | Scholar Rock Holding CORP | -0.7% | — | Add |
| 9 | IKT | Inhibikase Therapeutics INC | -1.2% | — | Unchanged |
| 10 | NUVL | Nuvalent Inc-a | -2.3% | — | Unchanged |
| 11 | ELVN | Enliven Therapeutics INC | -2.9% | — | Add |
| 12 | SYRE | Spyre Therapeutics INC | -4% | — | Unchanged |
| 13 | APGE | Apogee Therapeutics INC | -4.6% | — | Unchanged |
| 14 | AXSM | Axsome Therapeutics INC | -5.8% | — | Unchanged |
| 15 | ABVX | Abivax Sa-adr | — | NEW | New buy |
| 16 | JBIO | Jade Biosciences INC | — | NEW | New buy |
| 17 | ✓ | Crescent Biopharma INC. | — | NEW | New buy |
| 18 | BCAX | Bicara Therapeutics INC | — | EXIT | Sold out |